Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05956847

The Role of Extracellular DNA (ecDNA) in the Occurrence and Development of Gastric

The Role of Extracellular DNA (ecDNA) in the Occurrence and Development of Gastric Cancer: an Exploratory Multicenter Prospective Observational Clinical Study

Status
Recruiting
Phase
Study type
Observational
Enrollment
1,000 (estimated)
Sponsor
Xijing Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

ECDNA is almost non-existent in normal cells, but exists in nearly half of human cancer cells, indicating that studying such abnormal DNA is of great significance for our understanding of tumor formation and evolution. The changes in ecDNA expression in intestinal type gastric cancer may be closely related to the occurrence and development of gastric cancer. Dynamic monitoring of changes in ecDNA expression in the gastric mucosa may help predict the occurrence of gastric cancer and guide subsequent treatment. By collaborating with multiple endoscopic centers to conduct gastroscopy biopsies on patients with gastric precancerous lesions, we aim to further explore the role of ecDNA in the occurrence and development of gastric cancer through continuous follow-up.

Conditions

Interventions

TypeNameDescription
PROCEDUREgastroscopyWhen performing gastroscopy, the endoscopist will perform a biopsy based on the condition of gastric mucosal lesions, with one specimen retained and the remaining specimens subjected to pathological examination

Timeline

Start date
2023-08-10
Primary completion
2028-07-20
Completion
2030-07-30
First posted
2023-07-21
Last updated
2023-08-29

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05956847. Inclusion in this directory is not an endorsement.